Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy

PURPOSE: To construct an immune-related gene prognostic index (IRGPI) for colon cancer and elucidate the molecular and immune characteristics as well as the benefit of immune checkpoint inhibitor (ICI) therapy in IRGPI-defined groups of colon cancer. EXPERIMENTAL DESIGN: Transcriptional and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheng, Song, Jingru, Azami, Nisma Lena Bahaji, Sun, Mingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095944/
https://www.ncbi.nlm.nih.gov/pubmed/35572595
http://dx.doi.org/10.3389/fimmu.2022.802665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095944/
https://www.ncbi.nlm.nih.gov/pubmed/35572595
http://dx.doi.org/10.3389/fimmu.2022.802665

Ejemplares similares